These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27101208)

  • 1. In brief: New recommendations for use of metformin in renal impairment.
    Med Lett Drugs Ther; 2016 Apr; 58(1493):51. PubMed ID: 27101208
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in metformin utilisation and dose appropriateness in Australia.
    Moon J; Kumar SS; Graham GG; Baysari MT; Williams KM; Chen W; Viardot A; Greenfield JR; Day RO
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1489-1496. PubMed ID: 27568311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of metformin in the setting of mild-to-moderate renal insufficiency.
    Lipska KJ; Bailey CJ; Inzucchi SE
    Diabetes Care; 2011 Jun; 34(6):1431-7. PubMed ID: 21617112
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60?
    Bloomgarden Z
    Nat Rev Endocrinol; 2015 Dec; 11(12):693-4. PubMed ID: 26416220
    [No Abstract]   [Full Text] [Related]  

  • 5. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of metformin according to estimated glomerular filtration rate: the threshold and the equation are important.
    Rigalleau V; Lasseur C; Beauvieux MC; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
    Diabet Med; 2007 Dec; 24(12):1498-9. PubMed ID: 18042087
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks.
    Eurich DT; Majumdar SR; McAlister FA; Tsuyuki RT; Johnson JA
    Open Med; 2011; 5(1):e33-4. PubMed ID: 22046218
    [No Abstract]   [Full Text] [Related]  

  • 8. ADPKD and metformin: from bench to bedside.
    Capuano I; Riccio E; Caccavallo S; De Simone I; Pisani A
    Clin Exp Nephrol; 2019 Nov; 23(11):1341-1342. PubMed ID: 31346894
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin: fifty-two not out.
    Campbell IW
    J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782
    [No Abstract]   [Full Text] [Related]  

  • 10. Metformin: a biguanide.
    Tanja JJ; Langlass TM
    Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindications.
    Flory JH; Hennessy S
    JAMA Intern Med; 2015 Mar; 175(3):458-9. PubMed ID: 25561419
    [No Abstract]   [Full Text] [Related]  

  • 12. Metformin: intrinsic vasculoprotective properties.
    Wiernsperger NF
    Diabetes Technol Ther; 2000; 2(2):259-72. PubMed ID: 11469268
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin and other antidiabetic agents in renal failure patients.
    Lalau JD; Arnouts P; Sharif A; De Broe ME
    Kidney Int; 2015 Feb; 87(2):308-22. PubMed ID: 24599253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sitagliptin in the treatment of type 2 diabetes: insights five years after commercialisation].
    Scheen AJ; Van Gaal LF
    Rev Med Liege; 2013 Oct; 68(10):504-10. PubMed ID: 24298724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin.
    Bailey CJ; Turner RC
    N Engl J Med; 1996 Feb; 334(9):574-9. PubMed ID: 8569826
    [No Abstract]   [Full Text] [Related]  

  • 16. Metformin.
    Nurs Times; 2005 Oct 4-10; 101(40):37-8. PubMed ID: 16250540
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes drug could lead to longer life.
    Rosania K
    Lab Anim (NY); 2013 Sep; 42(9):312. PubMed ID: 23965554
    [No Abstract]   [Full Text] [Related]  

  • 18. Metformin in polycystic ovary syndrome.
    Fisken RA
    N Engl J Med; 2008 Apr; 358(17):1866-7; author reply 1868. PubMed ID: 18437727
    [No Abstract]   [Full Text] [Related]  

  • 19. Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
    Chandel NS; Avizonis D; Reczek CR; Weinberg SE; Menz S; Neuhaus R; Christian S; Haegebarth A; Algire C; Pollak M
    Cell Metab; 2016 Apr; 23(4):569-70. PubMed ID: 27076070
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin in polycystic ovary syndrome.
    Mascitelli L; Pezzetta F; Goldstein MR
    N Engl J Med; 2008 Apr; 358(17):1867-8; author reply 1868. PubMed ID: 18437729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.